TransMedics Group, Inc. (BIT:1TMDX)
Italy flag Italy · Delayed Price · Currency is EUR
106.20
+0.55 (0.52%)
At close: Mar 13, 2026

TransMedics Group Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
488.37336.65394.81201.1825.58
Short-Term Investments
----66.87
Cash & Short-Term Investments
488.37336.65394.81201.1892.45
Cash Growth
45.07%-14.73%96.25%117.61%-26.42%
Accounts Receivable
84.2897.7263.5827.615.93
Inventory
48.8846.5544.2420.6114.86
Other Current Assets
16.2516.298.032.95.46
Total Current Assets
637.78497.22510.65252.29118.71
Net Property, Plant & Equipment
332.81292.45180.4924.3515.69
Other Intangible Assets
1.952.152.35--
Goodwill
11.5511.5511.99--
Other Long-Term Assets
84.280.710.560.50.5
Total Assets
1,068804.08706.05277.15134.89
Accounts Payable
10.3510.2912.723.346.65
Accrued Expenses
62.7445.1538.2218.6416.34
Current Portion of Long-Term Debt
10----
Current Portion of Leases
3.312.732.041.44-
Unearned Revenue
2.911.741.960.240.25
Total Current Liabilities
89.3159.9154.9323.6623.24
Long-Term Debt
502.39509.31506.258.735.2
Long-Term Leases
3.586.257.717.428.6
Total Long-Term Liabilities
505.97515.56513.9166.1143.8
Total Liabilities
595.27575.47568.8589.7767.04
Common Stock
750.93697.21641.11666.28510.49
Accumulated Other Comprehensive Income
0.12-0.36-0.2-0.23-0.19
Retained Earnings
-277.95-468.24-503.71-478.68-442.45
Shareholders' Equity
473.1228.6137.2187.3867.85
Total Liabilities & Equity
1,068804.08706.05277.15134.89
Total Debt
519.28518.29515.9567.5643.8
Net Cash (Debt)
-30.91-181.64-121.13133.6348.65
Net Cash Growth
---174.66%-46.53%
Net Cash Per Share
-0.76-5.16-3.734.521.76
Book Value
473.1228.6137.2187.3867.85
Book Value Per Share
11.676.494.226.342.46
Tangible Book Value
459.6214.9122.86187.3867.85
Tangible Book Value Per Share
11.346.103.786.342.46
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.